For patients with cancer and chronic constipation, elobixibat was shown to be safe and effective during an observational study, the results of which were published in The Oncologist. Chronic constipation affects up to 87% of patients with cancer receiving palliative care and has been associated with reduced quality of life and extreme discomfort. To address…
A review of data from patients with CML treated with TKIs identified risk factors for developing pulmonary hypertension in these patients.
For five of six actinic damage and skin cancer index stages, consensus-based recommendations developed
Eight percent drop in screenings at 32 community health centers means about 47,517 fewer mammograms, 242 missed breast cancer diagnoses
There was no significant difference in the risk of hypersensitivity reactions with low-dose or high-dose dexamethasone.
SBRT was compared with external beam radiotherapy to determine which provided better pain control for patients with spinal metastases.
An analysis of studies showed that use of an angiotensin-converting enzyme inhibitor prevented cardiotoxicity in patients with cancer receiving an anthracycline.
Sepsis and septic shock are common oncologic emergencies that require vigilant, timely diagnosis and intervention. Timely and effective detection and treatment of these conditions are key to patient survival.
A phase 3 clinical trial determined if adding aprepitant to antiemetic prophylaxis would further reduce the risks of chemotherapy-induced nausea and vomiting for women receiving chemotherapy for GI cancer.
A review of the factors that contribute to the occurrence of extravasation in patients receiving IV treatments is presented with management steps.